@prefix config: . @prefix meta: . @prefix rdf: . @prefix rdfs: . @prefix xsd: . @prefix owl: . @prefix dc: . @prefix dcmitype: . @prefix dcterms: . @prefix foaf: . @prefix geo: . @prefix om: . @prefix locn: . @prefix schema: . @prefix skos: . @prefix dbpedia: . @prefix p: . @prefix yago: . @prefix units: . @prefix geonames: . @prefix prv: . @prefix prvTypes: . @prefix doap: . @prefix void: . @prefix ir: . @prefix ou: . @prefix teach: . @prefix time: . @prefix datex: . @prefix aiiso: . @prefix vivo: . @prefix bibo: . @prefix fabio: . @prefix vcard: . @prefix swrcfe: . @prefix frapo: . @prefix org: . @prefix ei2a: . @prefix pto: . ou:vecesCitado "110"; dcterms:creator "Gómez-Suaga P."; a ou:Publicacion; vivo:identifier "2018-718"; ou:bibtex "@article{733cd1fea4db4dcc9ce67887caf830ff,\n title = 'ER-mitochondria signaling in Parkinson's disease review-article',\n abstract = 'Mitochondria form close physical contacts with a specialized domain of the endoplasmic reticulum (ER), known as the mitochondria-associated membrane (MAM). This association constitutes a key signaling hub to regulate several fundamental cellular processes. Alterations in ER-mitochondria signaling have pleiotropic effects on a variety of intracellular events resulting in mitochondrial damage, Ca2+ dyshomeostasis, ER stress and defects in lipid metabolism and autophagy. Intriguingly, many of these cellular processes are perturbed in neurodegenerative diseases. Furthermore, increasing evidence highlights that ER-mitochondria signaling contributes to these diseases, including Parkinson's disease (PD). PD is the second most common neurodegenerative disorder, for which effective mechanism-based treatments remain elusive. Several PD-related proteins localize at mitochondria or MAM and have been shown to participate in ER-mitochondria signaling regulation. Likewise, PD-related mutations have been shown to damage this signaling. Could ER-mitochondria associations be the link between pathogenic mechanisms involved in PD, providing a common mechanism? Would this provide a pharmacological target for treating this devastating disease? In this review, we aim to summarize the current knowledge of ER-mitochondria signaling and the recent evidence concerning damage to this signaling in PD.',\n author = 'Patricia G{\\'o}mez-Suaga and {Bravo-San Pedro}, {Jos{\\'e} M.} and Gonz{\\'a}lez-Polo, {Rosa A.} and Fuentes, {J. M.} and Mireia Niso-Santano',\n year = '2018',\n month = mar,\n day = '1',\n doi = '10.1038/s41419-017-0079-3',\n language = 'English',\n volume = '9',\n journal = 'Cell Death and Disease',\n issn = '2041-4889',\n publisher = 'Nature Publishing Group',\n number = '3',\n}"; dcterms:publisher "Cell Death and Disease"; vcard:url ; bibo:volume "9"; ou:tipoPublicacion "Review"; dcterms:contributor "Gomez-Suaga P., Bravo-San Pedro J.M., Gonzalez-Polo R.A., Fuentes J.M., Niso-Santano M."; ou:urlOrcid ; ou:urlScopus ; ou:eid "2-s2.0-85042859594"; ou:openaccess "1"^^xsd:boolean; bibo:eissn "2041-4889"; bibo:doi "10.1038/s41419-017-0079-3"; fabio:hasPublicationYear "2018"; dcterms:title "ER-mitochondria signaling in Parkinson's disease review-article"; ou:publicadaEnRevista , . ou:tienePublicacion . ou:tienePublicacion . ou:tienePublicacion . ou:tienePublicacion .